TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $5,210,000 | +11.8% | 309,541 | +21.3% | 0.24% | -14.7% |
| Q1 2021 | $4,660,000 | -22.2% | 255,189 | -22.4% | 0.28% | -41.6% |
| Q4 2020 | $5,989,000 | +1.3% | 329,045 | -0.7% | 0.49% | -6.0% |
| Q3 2020 | $5,914,000 | +23.2% | 331,484 | +23.8% | 0.52% | -5.8% |
| Q2 2020 | $4,800,000 | +17.8% | 267,684 | -0.3% | 0.55% | -39.3% |
| Q1 2020 | $4,076,000 | -50.0% | 268,510 | -35.0% | 0.91% | +6.3% |
| Q4 2019 | $8,156,000 | – | 413,400 | – | 0.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |